Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Votel Joseph L.Director | Grant or award | A | — 1,047 sh | Jul 6, 2026 |
| 16 | Renfroe Sean GGENERAL COUNSEL | Open-market sale · 10b5-1 plan | SELL | $82K 426 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 16 | Knight Lea DanielsEVP & Chief Financial Officer | Tax withholding | F | $94K 5,226 sh | Jul 6, 2026 traded Jul 3, 2026 |
| 15 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 752 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Stojanovic DanijelaInterim CFO | Grant or award | A | — 22.5K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Ham Margaret MDirector | Grant or award | A | — 415 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Hancock MarkDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $274K 6,080 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Harris Robert E.SVP & Chief Accounting Oficer | Option exercise | M | — 1,516 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Chakravarthy ArthiChief Legal Officer | Tax withholding | F | $41K 7,032 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | O'Brien Michael GrahamCFO | Option exercise | M | — 1,555 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Kellenberger PaulDirector, Chief Executive Officer | Option exercise | M | — 1,340 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Njoku NnamdiPresident & COO | Grant or award | A | — 12.3K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Blevins ChristopherGeneral Counsel | Tax withholding | F | $17.3 5 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | O'Brien Michael GrahamCFO | Option exercise | M | — 223 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Rome Marc D.SVP, Gen. Counsel & Corp. Sec. | Tax withholding | F | $3,544 226 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Blevins ChristopherGeneral Counsel | Option exercise | M | — 12 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Cornelius CraigDirector, President & CEO | Tax withholding | F | — 7,184 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 1,067 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Malkani Dhiraj HCHIEF STRATEGY OFFICER | Grant or award | A | — 82.6K sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | DeOliveira ErickChief Financial Officer | Option exercise | M | — 164 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Blevins ChristopherGeneral Counsel | Option exercise | M | — 12 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Woodward Sean ThomasCFO | Grant or award | A | $14K 97 sh | Jul 6, 2026 traded Jun 30, 2026 |
| 15 | Kellenberger PaulDirector, Chief Executive Officer | Option exercise | M | — 2,680 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Minor BradleyChief Marketing Officer | Option exercise | M | — 4,441 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Geer Charles H. IIEVP, Industrial Services | Tax withholding | F | $12K 40 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Malkani Dhiraj HCHIEF STRATEGY OFFICER | Grant or award | A | — 2,188 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Graff Marc D.SVP & Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $59K 126 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Chakravarthy ArthiChief Legal Officer | Tax withholding | F | $20K 3,336 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Wyrick JasonEVP, Technology | Tax withholding | F | $37K 1,286 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Bhagwakar Ranjana NEVP, Business Operations | Grant or award | A | — 9,048 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Villanueva Rodriguez AlfonsoEVP&Int.Group CEO-VZ Cons.&CTO | Grant or award | A | $1,046 87 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | O'Brien Michael GrahamCFO | Option exercise | M | — 7,118 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Germano Judith HDirector | Grant or award | A | $18K 439 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise | M | — 7,218 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Lewis Michelle ReneeChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $189K 4,200 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | DeOliveira ErickChief Financial Officer | Option exercise | M | — 680 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Oman David WChief Risk Officer | Option exercise | M | — 2,748 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Malkani Dhiraj HCHIEF STRATEGY OFFICER | Grant or award | A | — 2,119 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Malkani Dhiraj HCHIEF STRATEGY OFFICER | Grant or award | A | — 1,245 sh | Jul 6, 2026 traded Jul 1, 2026 |
| 15 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $710K 2,600 sh | Jul 6, 2026 traded Jul 1, 2026 |